Lendtable vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF fintech providing credit to help employees fully capture 401(k) employer match and ESPP benefits; $72.3M YC-backed with SoftBank investment at Microsoft, Google, Amazon employees.
About
Lendtable is a San Francisco-based fintech company providing lines of credit to salaried employees to fully capture their employer 401(k) match and ESPP (Employee Stock Purchase Plan) benefits — solving the underutilization problem where employees who can't afford to divert sufficient paycheck to 401(k) contributions leave matching employer funds uncaptured. Founded and backed by Y Combinator (W20) with $72.3 million raised including an $18 million Series A led by O1 Advisors with participation from SoftBank's SB Opportunity Fund and Valor Equity Partners, Lendtable has disbursed over $2.4 million in match benefits to employees at Microsoft, Google, Amazon, and IBM.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.